The role of hematopoietic growth factors in special populations with chronic hepatitis C

Article Type
Changed
Tue, 10/30/2018 - 12:14
Display Headline
The role of hematopoietic growth factors in special populations with chronic hepatitis C
Patients with HIV coinfection, end-stage renal disease, or liver transplantation
Article PDF
Author and Disclosure Information

Stevan A. Gonzalez, MD
Center for the Study of Hepatitis C and the Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, New York, NY

Ira M. Jacobson, MD
Center for the Study of Hepatitis C and the Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, New York, NY

Correspondence: Ira M. Jacobson, MD, Chief, Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, 525 E. 68th Street, Room F-231, New York, NY 10021; email: [email protected]

Dr. Gonzalez reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Jacobson reported that he has received grant or research support from and served on the speakers’ bureau of the Schering-Plough corporation and serves as a consultant to the Amgen, Ortho Biotech, and Schering-Plough corporations.

Publications
Page Number
S22-S26
Author and Disclosure Information

Stevan A. Gonzalez, MD
Center for the Study of Hepatitis C and the Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, New York, NY

Ira M. Jacobson, MD
Center for the Study of Hepatitis C and the Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, New York, NY

Correspondence: Ira M. Jacobson, MD, Chief, Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, 525 E. 68th Street, Room F-231, New York, NY 10021; email: [email protected]

Dr. Gonzalez reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Jacobson reported that he has received grant or research support from and served on the speakers’ bureau of the Schering-Plough corporation and serves as a consultant to the Amgen, Ortho Biotech, and Schering-Plough corporations.

Author and Disclosure Information

Stevan A. Gonzalez, MD
Center for the Study of Hepatitis C and the Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, New York, NY

Ira M. Jacobson, MD
Center for the Study of Hepatitis C and the Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, New York, NY

Correspondence: Ira M. Jacobson, MD, Chief, Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, 525 E. 68th Street, Room F-231, New York, NY 10021; email: [email protected]

Dr. Gonzalez reported that he has no commercial affiliations or interests that pose a potential conflict of interest with this article.

Dr. Jacobson reported that he has received grant or research support from and served on the speakers’ bureau of the Schering-Plough corporation and serves as a consultant to the Amgen, Ortho Biotech, and Schering-Plough corporations.

Article PDF
Article PDF
Patients with HIV coinfection, end-stage renal disease, or liver transplantation
Patients with HIV coinfection, end-stage renal disease, or liver transplantation
Page Number
S22-S26
Page Number
S22-S26
Publications
Publications
Article Type
Display Headline
The role of hematopoietic growth factors in special populations with chronic hepatitis C
Display Headline
The role of hematopoietic growth factors in special populations with chronic hepatitis C
Citation Override
Cleveland Clinic Journal of Medicine 2004 May;71(suppl 3):S22-S26
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media